PhotoBiotics
London
About PhotoBiotics
PhotoBiotics is develops targeted therapeutics for MRI imaging and cancer treatment. It provides OptiLink, a conjugation platform that enables multiple attachment of drugs to antibody fragments for better drug delivery in imaging and therapy; antibody-drug conjugates; and ProstaLite, a targeted light activated cancer therapy solution.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $580.3K
- Last round: Series Unknown (May 2010)
- Website: photobiotics.com
- Phone: +44 77 1158 0914
Industries & Categories
Biotechnology, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/photobiotics-2008928 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.